We are live on ! Find out more
TEVA icon

Teva Pharmaceuticals
TEVA

772 hedge funds and large institutions have $29.6B invested in Teva Pharmaceuticals in 2014 Q3 according to their latest regulatory filings, with 60 funds opening new positions, 254 increasing their positions, 309 reducing their positions, and 65 closing their positions.

New
Increased
Maintained
Reduced
Closed

128% more call options, than puts

Call options by funds: $1.34B | Put options by funds: $589M

14% more capital invested

Capital invested by funds: $26B → $29.6B (+$3.61B)

0.48% more ownership

Funds ownership: 52.26% → 52.74% (+0.48%)

1% less funds holding

Funds holding: 779 → 772 (-7)

8% less first-time investments, than exits

New positions opened: 60 | Existing positions closed: 65

4% less funds holding in top 10

Funds holding in top 10: 49 → 47 (-2)

18% less repeat investments, than reductions

Existing positions increased: 254 | Existing positions reduced: 309

Holders
772
Holders Change
-7
Holders Change %
-0.9%
% of All Funds
22.4%
Holding in Top 10
47
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-4.08%
% of All Funds
1.36%
New
60
Increased
254
Reduced
309
Closed
65
Calls
$1.34B
Puts
$589M
Net Calls
+$755M
Net Calls Change
-$241M

Top Buyers

Rank Fund Capital Flow
1
WRF
Waddell & Reed Financial
Kansas
+$376M
2
Boston Partners
Boston Partners
Massachusetts
+$259M
3
William Blair & Company
William Blair & Company
Illinois
+$246M
4
BA
BlackRock Advisors
Delaware
+$143M
5
SCM
Scopia Capital Management
New York
+$141M

Top Sellers

Rank Fund Capital Flow
1
Norges Bank
Norges Bank
Norway
-$500M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$164M
3
Bank of America
Bank of America
North Carolina
-$148M
4
Bank of New York Mellon
Bank of New York Mellon
New York
-$132M
5
PC
PointState Capital
New York
-$110M
Name Holding Trade Value Shares
Change 		Change in
Stake
HP
776
Holowesko Partners
Bahamas
– -$38.2M -729,671 Closed
SOMRS
777
State of Michigan Retirement System
Michigan
– -$31.7M -605,097 Closed
TCSAM
778
Tyrus Capital S.A.M.
Monaco
– -$25.2M -481,463 Closed
Alyeska Investment Group
779
Alyeska Investment Group
Illinois
– -$12.1M -231,640 Closed
PP
780
PDT Partners
New York
– -$10.8M -205,239 Closed
KCM
781
Kingdon Capital Management
New York
– -$10.5M -200,000 Closed
LSC
782
Lesa Sroufe & Co
Washington
– -$8.56M -163,218 Closed
AC
783
Ascend Capital
California
– -$6.58M -125,515 Closed
RCM
784
Royal Capital Management
New York
– -$6.03M -115,000 Closed
HCMT
785
Highland Capital Management (Texas)
Texas
– -$5.28M -100,645 Closed
GTC
786
Ghost Tree Capital
New York
– -$5.24M -100,000 Closed
OAM
787
Oxford Asset Management
United Kingdom
– -$4.96M -94,567 Closed
BCMU
788
BlueCrest Capital Management (UK)
Guernsey
– -$4.91M -93,646 Closed
FMLI
789
Fukoku Mutual Life Insurance
Japan
– -$4.4M -84,000 Closed
PRCM
790
Pine River Capital Management
Minnesota
– -$4M -76,400 Closed
PCM
791
Palisade Capital Management
New Jersey
– -$3.44M -65,722 Closed
SIC
792
Salem Investment Counselors
North Carolina
– -$2.87M -54,782 Closed
IHM
793
Iguana Healthcare Management
New York
– -$2.62M -50,000 Closed
LOM
794
Loeb Offshore Management
New York
– -$2.57M -48,982 Closed
SFP
795
Santa Fe Partners
New Mexico
– -$2.45M -46,737 Closed
MIH
796
Madison Investment Holdings
Wisconsin
– -$2.2M -42,000 Closed
CA
797
Cullinan Associates
Kentucky
– -$1.5M -38,200 Closed
AB
798
AT Bancorp
Iowa
– -$1.72M -32,884 Closed
ID
799
Integral Derivatives
New York
– -$1.51M -28,539 Closed
BCM
800
Basswood Capital Management
New York
– -$1.39M -26,466 Closed
30 31
32
33 34

TEVA Hedge Fund Activity: Q3 2014 in Review

772 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Teva Pharmaceuticals (TEVA) for Q3 2014, worth a combined $29.6B — up 14% from $26B a quarter earlier.

Sellers outnumbered buyers: 65 funds closed out of TEVA and 60 opened new positions — a net loss of 5 holders — while 309 trimmed existing stakes and 254 added.

The largest buyer was Waddell & Reed Financial, adding an estimated $376M. The largest seller was Norges Bank, cutting an estimated $500M.

  • 772 institutional investors held Teva Pharmaceuticals (TEVA) as of Q3 2014, down from 779 in Q2 2014.
  • Funds reported $29.6B of Teva Pharmaceuticals stock for Q3 2014, up 14% quarter-over-quarter.
  • 60 funds opened new Teva Pharmaceuticals positions in Q3 2014 and 65 closed out, a net change of -5 holders.
  • The largest Teva Pharmaceuticals buyer in Q3 2014 was Waddell & Reed Financial, an estimated $376M added.
  • The largest Teva Pharmaceuticals seller in Q3 2014 was Norges Bank, an estimated $500M sold.

Based on aggregated 13F filings for Q3 2014.